Insider Trading & Ownership of Preston Klassen

Location: San Diego, CA
Summary: The estimated net worth of Preston Klassen is at least $1,034,383 dollars as of 27 Jun 2025. Preston Klassen is the Director of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $650.5K. Preston Klassen is the President & Head of R & D, Director of Regulus Therapeutics Inc. and owns shares of Regulus Therapeutics Inc. stock worth about $383.8K.
Signature: /s/ Christopher Aker, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Preston Klassen files a new Insider Trading report.

Ownership of Preston Klassen

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
MTCR	Metacrine, Inc.	Director	$650,535			23 Mar 2023
RGLS	Regulus Therapeutics Inc.	President & Head of R & D, Director	$383,848	+$95,852	+33%	25 Jun 2025
ZURA	Zura Bio Ltd	President and COO				20 Mar 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.